top of page
News
Stay Informed About UMG
UMG had partially licensed one of its patented enzymatic techniques to Ibex Bioscience LLC in 2017
UMG has established collaborative projects with Vast Sea Biotechnology Inc. since 2020 to develop several R&D products including a new nutrition supplement of AVL-19 to support human immunity; it has been launched into the global markets
AVL-19
bottom of page